Mezym (Amylase, Lipase, Protease)

The three enzymes in Mezym act in the gastrointestinal tract: amylase hydrolyzes starches into simple sugars, lipase splits triglycerides into fatty acids and glycerol, and protease cleaves peptide bonds to release amino acids. By supplying these enzymes externally, Mezym supplements the body's own pancreatic secretions, enhancing nutrient digestion and absorption.

The dosage of Mezym is individualized. A qualified prescriber determines the appropriate amount based on the patient’s degree of pancreatic insufficiency, body weight, dietary intake, and clinical response. Patients should follow the prescribing clinician’s instructions and not adjust the dose without medical guidance.

Safety data for Mezym in pregnancy and lactation are limited. Because the product contains enzymes that are not systemically absorbed in significant amounts, it is generally considered low risk, but the prescriber should evaluate the benefit‑risk balance for each individual. Women who are pregnant or nursing should discuss use with their healthcare provider.

To request Mezym, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Mezym contains a combination of amylase, lipase, and protease, similar to many pancreatic enzyme replacement therapies. Compared with single‑enzyme preparations, Mezym offers a broader spectrum of macronutrient digestion. The specific enzyme activity units, formulation, and excipients may differ from competitors, influencing factors such as dosing frequency, tolerability, and cost. Clinicians select the product that best matches the patient’s clinical profile.

Mezym should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat. Do not store in a bathroom or near a kitchen stove. Ensure the container is tightly closed after each use to maintain enzyme stability.

Mezym is taken orally, usually with meals or snacks that contain the nutrients to be digested. The tablets or capsules should be swallowed whole with a full glass of water unless the prescribing information advises otherwise. Timing the dose with food maximizes the enzymes’ contact with ingested macronutrients, improving their effectiveness.

The most serious risks include allergic reactions that can progress to anaphylaxis, severe abdominal pain indicating possible pancreatitis exacerbation, and rare cases of eosinophilia or significant serum amylase elevation. Patients should seek immediate medical attention if they experience swelling of the face or throat, difficulty breathing, persistent vomiting, or intense abdominal pain.

Mezym is contraindicated in individuals with a known hypersensitivity to any of its enzyme components or excipients. It should also be avoided in patients with active gastrointestinal bleeding, severe acute pancreatitis, or those who are unable to swallow oral dosage forms. The prescriber must assess each patient’s medical history before initiating therapy.